Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Kirkham

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Arthritis and Rheumatism|October 11, 2001
Prospective evaluation of magnetic resonance imaging and physical examination findings in patients with greater trochanteric pain syndromeP A Bird, S P Oakley, R Shnier, et al.
Scandinavian Journal of Rheumatology|October 9, 2002
Effects of a PEGylated soluble TNF receptor type 1 (PEG sTNF-RI) on cytokine expression in adjuvant arthritisK A Bush, J S Walker, J Frazier, et al.
Clinical and Experimental Immunology|April 12, 2001
Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early diseaseK A Bush, J S Walker, C S Lee, et al.
The Journal of Rheumatology|September 1, 1994
In vivo analysis of disease modifying drug therapy activity in rheumatoid arthritis by sequential immunohistological analysis of synovial membrane interleukin 1 betaB W Kirkham, F J Navarro, M M Corkill, et al.
Arthritis and Rheumatism|October 31, 2009
Functional and work outcomes improve in patients with rheumatoid arthritis who receive targeted, comprehensive occupational therapyAlyssa M Macedo, Stephen P Oakley, Gabriel S Panayi, et al.
The Journal of Rheumatology|June 1, 1991
Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responsesB W Kirkham, M M Corkill, S C Davison, et al.
Arthritis and Rheumatism|March 29, 2002
Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion proteinKatherine A Bush, Katherine M Farmer, Judith S Walker, et al.
Therapeutic Advances in Musculoskeletal Disease|June 15, 2026
Towards an individualised approach to pain management in inflammatory arthritisZoe Rutter-Locher, Franziska Denk, Leonie S Taams, et al.
Annals of the Rheumatic Diseases|July 7, 2019
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversiesDennis G McGonagle, Iain B McInnes, Bruce W Kirkham, et al.
The Journal of Rheumatology|June 1, 1993
Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapyB W Kirkham, S C Davison, M M Corkill, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Arthritis and Rheumatism|October 11, 2001
Prospective evaluation of magnetic resonance imaging and physical examination findings in patients with greater trochanteric pain syndromeP A Bird, S P Oakley, R Shnier, et al.
Scandinavian Journal of Rheumatology|October 9, 2002
Effects of a PEGylated soluble TNF receptor type 1 (PEG sTNF-RI) on cytokine expression in adjuvant arthritisK A Bush, J S Walker, J Frazier, et al.
Clinical and Experimental Immunology|April 12, 2001
Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early diseaseK A Bush, J S Walker, C S Lee, et al.
The Journal of Rheumatology|September 1, 1994
In vivo analysis of disease modifying drug therapy activity in rheumatoid arthritis by sequential immunohistological analysis of synovial membrane interleukin 1 betaB W Kirkham, F J Navarro, M M Corkill, et al.
Arthritis and Rheumatism|October 31, 2009
Functional and work outcomes improve in patients with rheumatoid arthritis who receive targeted, comprehensive occupational therapyAlyssa M Macedo, Stephen P Oakley, Gabriel S Panayi, et al.
The Journal of Rheumatology|June 1, 1991
Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responsesB W Kirkham, M M Corkill, S C Davison, et al.
Arthritis and Rheumatism|March 29, 2002
Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion proteinKatherine A Bush, Katherine M Farmer, Judith S Walker, et al.
Therapeutic Advances in Musculoskeletal Disease|June 15, 2026
Towards an individualised approach to pain management in inflammatory arthritisZoe Rutter-Locher, Franziska Denk, Leonie S Taams, et al.
Annals of the Rheumatic Diseases|July 7, 2019
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversiesDennis G McGonagle, Iain B McInnes, Bruce W Kirkham, et al.
The Journal of Rheumatology|June 1, 1993
Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapyB W Kirkham, S C Davison, M M Corkill, et al.
Pageof 8